Intramolecular Diels-Alder and tandem intramolecular Diels-Alder/1,3-dipolar cycloaddition reactions of 1,3,4-oxadiazoles

The scope of intramolecular Diels-Alder and a novel tandem Diels-Alder/1,3-dipolar cycloaddition cascade of 1,3,4-oxadiazoles is disclosed. In the cases examined, the tandem cycloadditions construct three new rings with formation of four new C-C bonds and set all six stereocenters about a central six-membered ring in a single step including three contiguous and four total quaternary centers without a trace of a second diastereomer.     

Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide

A chimera composed of the natural products radicicol and geldanamycin has been prepared through an amide linkage connecting the resorcinol moiety of radicicol to the quinone ring of geldanamycin. The inhibitory activity of these compounds was determined by their ability to inhibit Hsp90's inherent ATPase activity along with degradation of the Hsp90 client protein, HER-2 in MCF-7 breast cancer cells. [reaction: see text]     

Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors

Development of heat shock protein 90 (Hsp90) C‐terminal inhibitors has emerged as an exciting strategy for the treatment of cancer. Previous efforts have focused on modifications to the natural products novobiocin and coumermycin. Moreover, variations in both the sugar and amide moieties have been extensively studied, whereas replacements for the coumarin core have received less attention. Herein, 24 cores were synthesized with varying distances and angles between the sugar and amide moieties. Compounds that exhibited good anti‐proliferative activity against multiple cancer cell lines and Hsp90 inhibitory activity, were those that placed the sugar and amide moieties between 7.7 and 12.1 Å apart along with angles of 180°.     

Structure-Based Design,Synthesis, and Biological Evaluation of Hsp90β-Selective Inhibitors

The 90 kDa heat shock proteins (Hsp90) are molecular chaperones that are responsible for the folding and/or trafficking of ∼400 client proteins, many of which are directly associated with cancer progression. Consequently, inhibition of Hsp90 can exhibit similar activity as combination therapy as multiple signaling nodes can be targeted simultaneously. In fact, seventeen small-molecule inhibitors that bind the Hsp90 N-terminus entered clinical trials for the treatment of cancer, all of which exhibited pan-inhibitory activity against all four Hsp90 isoforms. Unfortunately, most demonstrated undesired effects alongside induction of the pro-survival heat shock response. As a result, isoform-selective inhibitors have been sought to overcome these detriments. Described herein is a structure-based approach to design Hsp90β-selective inhibitors along with preliminary SAR. In the end, compound 5 was shown to manifest ∼370-fold selectivity for Hsp90β versus Hsp90α, and induced the degradation of select Hsp90β-dependent clients. These data support the development of Hsp90β-selective inhibitors as a new paradigm to overcome the detriments associated with pan-inhibition of Hsp90.     

Isomerism in rhodium(I) N,S-donor heteroscorpionates: ring substituent and ancillary ligand effects

The heteroscorpionate ligands [HB(taz)(2)(pz(R))](-) (pz(R) = pz, pz(Me2), pz(Ph)) and [HB(taz)(pz)(2)](-), synthesised from the appropriate potassium hydrotris(pyrazolyl)borate salt and 4-ethyl-3-methyl-5-thioxo-1,2,4-triazole (Htaz), react with [{Rh(cod)(μ-Cl)}(2)] to give [Rh(cod)Tx] {Tx = HB(taz)(2)(pz), HB(taz)(2)(pz(Me2)), HB(taz)(2)(pz(Ph)), HB(taz)(pz)(2)}; the heteroscorpionate rhodaboratrane [Rh{B(taz)(2)(pz(Me2))}{HB(taz)(2)(pz(Me2))}] is the only isolable product from the reaction of [{Rh(nbd)(μ-Cl)}(2)] with K[HB(taz)(2)(pz(Me2))]. Carbonylation of the cod complexes gave a mixture of [Rh(CO)(2)Tx] and [(RhTx)(2)(μ-CO)(3)] which reacts with PR(3) to give [Rh(CO)(PR(3))Tx] (R = Cy, NMe(2), Ph, OPh). In the solid state the complexes are square planar with the particular structure dependent on the steric and/or electronic properties of the scorpionate and ancillary ligands. The complex [Rh(cod){HB(taz)(pz)(2)}] has the heteroscorpionate κ(2)[N(2)]-coordinated to rhodium with the B-H bond directed away from the rhodium square plane while [Rh(cod){HB(taz)(2)(pz(Me2))}] is κ(2)[SN]-coordinated, with the B-H bond directed towards the metal. The complexes [Rh(CO)(PPh(3)){HB(taz)(2)(pz)}] and [Rh(CO)(PPh(3)){HB(taz)(2)(pz(Me2))}] are also κ(2)[SN]-coordinated but with the pyrazolyl ring cis to PPh(3); in the former the B-H bond is directed towards rhodium while in the latter the ring is pseudo-parallel to the rhodium square plane, as also found for [Rh(CO)(2){HB(taz)(2)(pz(Me2))}]. The analogues [Rh(CO)(PR(3)){HB(taz)(2)(pz(Me2))}] (R = Cy, NMe(2)) have the phosphines trans to the pyrazolyl ring. Uniquely, [Rh(CO)(PPh(3)){HB(taz)(2)(pz(Ph))}] is κ(2)[S(2)]-coordinated. A qualitative mechanism is given for the rapid ring-exchange, and hence isomerisation, observed in solution.